|
DK0662320T3
(da)
*
|
1991-08-30 |
2001-09-24 |
Showa Pharm Chem Ind |
Tør gelsammensætning
|
|
US5605930A
(en)
*
|
1991-10-21 |
1997-02-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
Compositions and methods for treating and preventing pathologies including cancer
|
|
EP0620001A1
(en)
*
|
1993-04-16 |
1994-10-19 |
McNEIL-PPC, INC. |
Aqueous pharmaceutical suspension and process for preparation thereof
|
|
FR2713931B1
(fr)
*
|
1993-12-20 |
1996-04-05 |
Laurence Paris |
Nouvelles compositions pharmaceutiques liquides à base d'ibuprofène et leur procédé de préparation.
|
|
NZ272574A
(en)
*
|
1995-07-14 |
1999-02-25 |
Lilly Eli & Co Nz Ltd |
Aqueous base suspension concentrate containing at least one ionophore antibiotic and wetting agent and/or a surfactant and xanthan gum optionally with a suspension agent, an antifreeze agent and an antifoaming agent; drench for veterinary treatment
|
|
WO1997003650A1
(en)
*
|
1995-07-14 |
1997-02-06 |
Eli Lilly & Company (Nz) Limited |
Ionophore antibiotic formulations
|
|
NZ280384A
(en)
|
1995-11-02 |
1997-01-29 |
Lilly Eli & Co Nz Ltd |
Animal feed supplement comprising a wettable powder composition of an ionophore antibiotic
|
|
AUPN862596A0
(en)
*
|
1996-03-12 |
1996-04-04 |
F.H. Faulding & Co. Limited |
Pharmaceutical compositions
|
|
CN1220598A
(zh)
*
|
1996-05-02 |
1999-06-23 |
大正制药株式会社 |
水难溶性酸性药物的悬浮液
|
|
US5712310A
(en)
*
|
1996-06-14 |
1998-01-27 |
Alpharma Uspd, Inc. |
Suspension of substantially water-insoluble drugs and methods of their manufacture
|
|
WO2000024273A1
(en)
*
|
1998-10-28 |
2000-05-04 |
San-Ei Gen F.F.I., Inc. |
Compositions containing sucralose and application thereof
|
|
US20110189348A1
(en)
*
|
1998-10-28 |
2011-08-04 |
San-Ei Gen F.F.I., Inc. |
Compositions containing sucralose and application thereof
|
|
USH2044H1
(en)
|
1998-11-02 |
2002-09-03 |
Mcneil-Ppc, Inc. |
Container with retaining member
|
|
BR0009557A
(pt)
|
1999-04-06 |
2002-05-28 |
Ethypharm Lab Prod Ethiques |
Suspensão farmacêutica para beber de ibuprofeno
|
|
US6211246B1
(en)
*
|
1999-06-10 |
2001-04-03 |
Mcneil-Ppc, Inc. |
Rapidly absorbed liquid compositions
|
|
US6726922B1
(en)
|
1999-06-28 |
2004-04-27 |
Minu, L.L.C. |
Process and composition for temporarily suppressing pain
|
|
ES2255557T3
(es)
|
2000-05-31 |
2006-07-01 |
Pepsico, Inc. |
Colorante alimenticio naranja de baja capacidad de manchar.
|
|
EP1305637A2
(en)
*
|
2000-08-02 |
2003-05-02 |
Malope Company Limited |
Diagnosis and treatment of non-ulcer dyspepsia based on hypothalamic-pituitary-adrenal axis abnormality
|
|
WO2002051384A1
(fr)
*
|
2000-12-25 |
2002-07-04 |
Chugai Seiyaku Kabushiki Kaisha |
Procede pour stabiliser une suspension et suspension stabilisee
|
|
ATE329578T1
(de)
*
|
2001-02-14 |
2006-07-15 |
Forte Iq B V |
Pharmazeutische zusammensetzung enthaltend xanthangummi
|
|
WO2002072102A1
(en)
*
|
2001-03-05 |
2002-09-19 |
Ortho-Mcneil Pharmaceutical, Inc. |
Taste masked liquid pharmaceutical compositions
|
|
CA2443089C
(en)
*
|
2001-04-03 |
2011-11-01 |
Schering Corporation |
Antifungal suspension of micronized posaconazole
|
|
WO2003011306A1
(en)
*
|
2001-07-31 |
2003-02-13 |
Wyeth |
Sucralose formulations to mask unpleasant tastes
|
|
US6770263B1
(en)
*
|
2001-10-01 |
2004-08-03 |
Naturewell, Incorporated |
Compositions and methods for the treatment of aches and pains
|
|
US20040132823A1
(en)
*
|
2001-11-02 |
2004-07-08 |
Leo Pavliv |
Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
|
|
ES2197781B1
(es)
*
|
2001-12-04 |
2005-02-16 |
Farmalider, S.A. |
Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno.
|
|
US6998480B2
(en)
|
2002-03-08 |
2006-02-14 |
Tate & Lyle Public Limited Company |
Process for improving sucralose purity and yield
|
|
US7049435B2
(en)
|
2002-03-08 |
2006-05-23 |
Tate & Lyle Public Limited Company |
Extractive methods for purifying sucralose
|
|
US7300670B2
(en)
|
2002-04-03 |
2007-11-27 |
Unilab Pharmatech, Ltd. |
Oral suspension formulation
|
|
CN101862292A
(zh)
*
|
2002-06-17 |
2010-10-20 |
塔罗制药美国公司 |
布洛芬混悬剂
|
|
US20030232097A1
(en)
*
|
2002-06-17 |
2003-12-18 |
Strides Inc. |
Oily wax matrix suspension formulation comprising ibuprofen free acid and potassium salt of ibuprofen
|
|
KR100509432B1
(ko)
*
|
2002-12-13 |
2005-08-22 |
주식회사 동구제약 |
Ｓ(+)-이부프로펜을 함유한 시럽제 조성물 및 그의 제조방법
|
|
US20040253311A1
(en)
*
|
2002-12-18 |
2004-12-16 |
Roger Berlin |
Multi-layer tablet comprising non-steroidal anti-inflammatory drugs, decongestants and non-sedating antihist amines
|
|
CL2003002653A1
(es)
*
|
2002-12-18 |
2005-04-22 |
Wyeth Corp |
Composicion farmaceutica que comprende (a) un antiinflamatorio no esteroidal (nsaid), preferentemente ibuprofeno, (b) un descongestionante, preferentemente pseudoefedrina y (c) un antihistaminico, preferentemente clorfeniramina; metodo para su prepar
|
|
US20040186180A1
(en)
*
|
2003-03-21 |
2004-09-23 |
Gelotte Cathy K. |
Non-steroidal anti-inflammatory drug dosing regimen
|
|
KR101059057B1
(ko)
*
|
2003-09-12 |
2011-08-24 |
류가쿠산 가부시키가이샤 |
쓴맛을 차단할 수 있는 과립상 젤리 음료
|
|
US20050069590A1
(en)
*
|
2003-09-30 |
2005-03-31 |
Buehler Gail K. |
Stable suspensions for medicinal dosages
|
|
US20050095299A1
(en)
*
|
2003-10-30 |
2005-05-05 |
Wynn David W. |
Controlled release analgesic suspensions
|
|
US20050095300A1
(en)
*
|
2003-10-30 |
2005-05-05 |
Wynn David W. |
Controlled release analgesic suspensions
|
|
US20070190133A1
(en)
*
|
2004-10-27 |
2007-08-16 |
Bunick Frank J |
Dosage forms having a microreliefed surface and methods and apparatus for their production
|
|
US20060088587A1
(en)
*
|
2004-10-27 |
2006-04-27 |
Bunick Frank J |
Dosage forms having a microreliefed surface and methods and apparatus for their production
|
|
US20060088586A1
(en)
*
|
2004-10-27 |
2006-04-27 |
Bunick Frank J |
Dosage forms having a microreliefed surface and methods and apparatus for their production
|
|
US20060088593A1
(en)
|
2004-10-27 |
2006-04-27 |
Bunick Frank J |
Dosage forms having a microreliefed surface and methods and apparatus for their production
|
|
US20070281022A1
(en)
*
|
2004-10-27 |
2007-12-06 |
Bunick Frank J |
Dosage forms having a microreliefed surface and methods and apparatus for their production
|
|
US20060087051A1
(en)
*
|
2004-10-27 |
2006-04-27 |
Bunick Frank J |
Dosage forms having a microreliefed surface and methods and apparatus for their production
|
|
US8383159B2
(en)
*
|
2004-10-27 |
2013-02-26 |
Mcneil-Ppc, Inc. |
Dosage forms having a microreliefed surface and methods and apparatus for their production
|
|
US20060093631A1
(en)
*
|
2004-10-29 |
2006-05-04 |
Buehler Gail K |
Dye-free pharmaceutical suspensions and related methods
|
|
US20060093630A1
(en)
*
|
2004-10-29 |
2006-05-04 |
Buehler Gail K |
Dye-free pharmaceutical suspensions and related methods
|
|
US20060093629A1
(en)
*
|
2004-10-29 |
2006-05-04 |
Buehler Gail K |
Dye-free pharmaceutical suspensions and related methods
|
|
US20060094760A1
(en)
*
|
2004-11-04 |
2006-05-04 |
Fawzy Abdel A |
Composition, system and method of treatment of gastrointestinal disorders with nizatidine oral solution
|
|
US7611695B2
(en)
*
|
2004-11-15 |
2009-11-03 |
Ultradent Products, Inc. |
Flavored hemostatic and acid etching compositions
|
|
US8758816B2
(en)
*
|
2004-11-24 |
2014-06-24 |
Meda Pharmaceuticals Inc. |
Compositions comprising azelastine and methods of use thereof
|
|
US20070020330A1
(en)
|
2004-11-24 |
2007-01-25 |
Medpointe Healthcare Inc. |
Compositions comprising azelastine and methods of use thereof
|
|
DK2486942T3
(en)
|
2004-11-24 |
2019-01-28 |
Meda Pharmaceuticals Inc |
COMPOSITIONS CONTAINING AZELASTINE AND PROCEDURES FOR USING IT
|
|
PT1824493E
(pt)
*
|
2004-12-06 |
2008-11-18 |
Janssen Pharmaceutica Nv |
Suspensão oral que compreende meloxicam
|
|
ATE536867T1
(de)
|
2006-03-16 |
2011-12-15 |
Tris Pharma Inc |
Modifizierte freisetzungsformulierungen mit arznei-ion-austausch-harzkomplexen
|
|
GB2438287A
(en)
*
|
2006-05-19 |
2007-11-21 |
Norbrook Lab Ltd |
Stable aqueous suspension
|
|
US20080014275A1
(en)
*
|
2006-07-13 |
2008-01-17 |
Buehler Gail K |
Pharmaceutical suspensions and related methods
|
|
WO2008064192A2
(en)
|
2006-11-21 |
2008-05-29 |
Mcneil-Ppc, Inc. |
Modified release analgesic suspensions
|
|
WO2008109018A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Meda Pharmaceuticals Inc. |
Compositions comprising carisoprodol and methods of use thereof
|
|
CN101679844B
(zh)
*
|
2007-03-09 |
2014-06-18 |
赫尔克里士公司 |
用于油田的羟乙基纤维素的稳定硫代硫酸钠基流化聚合物悬浮液
|
|
US20080260837A1
(en)
*
|
2007-04-20 |
2008-10-23 |
Qpharma, L.L.C. |
Physically stable aqueous suspensions of active pharmaceuticals
|
|
US20080268025A1
(en)
*
|
2007-04-25 |
2008-10-30 |
Donald Spector |
Compositions Useful for Preventing Pain and Soreness Resulting from Exercise and Methods of Use
|
|
US9833510B2
(en)
*
|
2007-06-12 |
2017-12-05 |
Johnson & Johnson Consumer Inc. |
Modified release solid or semi-solid dosage forms
|
|
US20090162923A1
(en)
*
|
2007-12-20 |
2009-06-25 |
Young Jeffrey W |
Methods and Compositions for Digestion of Organic Waste
|
|
WO2009083759A1
(en)
*
|
2008-01-03 |
2009-07-09 |
Wockhardt Research Centre |
Oral pharmaceutical suspension comprising paracetamol and ibuprofen
|
|
US8436156B2
(en)
*
|
2008-01-04 |
2013-05-07 |
Tate & Lyle Technology Limited |
Method for the production of sucralose
|
|
EP2254677A1
(en)
*
|
2008-03-20 |
2010-12-01 |
Tate & Lyle Technology Limited |
Removal of acids from tertiary amide solvents
|
|
US8436157B2
(en)
*
|
2008-03-26 |
2013-05-07 |
Tate & Lyle Technology Limited |
Method for the production of sucralose
|
|
KR20100127875A
(ko)
*
|
2008-04-03 |
2010-12-06 |
테이트 앤드 라일 테크놀러지 리미티드 |
수크랄로오스 추출 효율에 대한 탄수화물 농도의 효과
|
|
AR071134A1
(es)
*
|
2008-04-03 |
2010-05-26 |
Tate & Lyle Technology Ltd |
Cristalizacion de sucralosa a partir de chorros que contienen sucralosa
|
|
US20090299055A1
(en)
*
|
2008-04-03 |
2009-12-03 |
Tate & Lyle Technology Limited |
Purification of Sucralose Containing Feed Streams for Sucralose Crystallization
|
|
US8497367B2
(en)
*
|
2008-04-03 |
2013-07-30 |
Tate & Lyle Technology Limited |
Sucralose purification process
|
|
WO2009124113A1
(en)
*
|
2008-04-03 |
2009-10-08 |
Tate & Lyle Technology Ltd. |
Extraction of less polar impurities from sucralose containing aqueous feed streams
|
|
HRP20140309T1
(hr)
|
2008-10-22 |
2014-05-09 |
Array Biopharma, Inc. |
SUPSTITUIRANI SPOJEVI PIRAZOLO[1,5-a]PIRIMIDINA KAO INHIBITORI TRK KINAZE
|
|
EP2405747A4
(en)
*
|
2009-03-13 |
2013-01-16 |
Nucitec Sa De Cv |
COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES
|
|
GB2469158B
(en)
|
2009-03-31 |
2011-09-28 |
Peter J Seaberg |
Base-assisted formation of tin-sucrose adducts
|
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
|
GB2474311B
(en)
*
|
2009-10-12 |
2012-10-17 |
Tate & Lyle Technology Ltd |
Low temperature, single solvent process for the production of sucrose-6-ester
|
|
GB2474310B
(en)
|
2009-10-12 |
2012-02-29 |
Tate & Lyle Technology Ltd |
Process for the production of sucrose-6-ester
|
|
GB201110520D0
(en)
|
2011-05-10 |
2011-08-03 |
Tate & Lyle Technology Ltd |
Extraction of carboxylic acids with tin compounds
|
|
EP3139769B1
(en)
|
2014-05-05 |
2022-06-22 |
California Safe Soil, LLC |
Nutrient rich compositions
|
|
JP6914834B2
(ja)
|
2014-11-16 |
2021-08-04 |
アレイ バイオファーマ インコーポレイテッド |
（Ｓ）−Ｎ−（５−（（Ｒ）−２−（２，５−ジフルオロフェニル）−ピロリジン−１−イル）−ピラゾロ［１，５−ａ］ピリミジン−３−イル）−３−ヒドロキシピロリジン−１−カルボキサミド硫酸水素塩の結晶形
|
|
EP3061501A1
(en)
|
2015-02-27 |
2016-08-31 |
Rottapharm Ltd. |
Composition for the treatment of acne
|
|
EP3117825A1
(en)
|
2015-07-16 |
2017-01-18 |
Rottapharm S.p.A. |
Oral formulation comprising berberine and morus alba extract
|
|
US11590228B1
(en)
|
2015-09-08 |
2023-02-28 |
Tris Pharma, Inc |
Extended release amphetamine compositions
|
|
TN2018000138A1
(en)
|
2015-10-26 |
2019-10-04 |
Array Biopharma Inc |
Point mutations in trk inhibitor-resistant cancer and methods relating to the same
|
|
US10045991B2
(en)
|
2016-04-04 |
2018-08-14 |
Loxo Oncology, Inc. |
Methods of treating pediatric cancers
|
|
AU2017246554B2
(en)
|
2016-04-04 |
2022-08-18 |
Loxo Oncology, Inc. |
Liquid formulations of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide
|
|
KR102566858B1
(ko)
|
2016-05-18 |
2023-08-11 |
어레이 바이오파마 인크. |
(s)-n-(5-((r)-2-(2,5-디플루오로페닐)피롤리딘-1-일)-피라졸로[1,5-a]피리미딘-3-일)-3-히드록시피롤리딘-1-카르복사미드의 제조 방법
|
|
JOP20190092A1
(ar)
|
2016-10-26 |
2019-04-25 |
Array Biopharma Inc |
عملية لتحضير مركبات بيرازولو[1، 5-a]بيريميدين وأملاح منها
|
|
JOP20190213A1
(ar)
|
2017-03-16 |
2019-09-16 |
Array Biopharma Inc |
مركبات حلقية ضخمة كمثبطات لكيناز ros1
|
|
US20200206352A1
(en)
*
|
2017-08-31 |
2020-07-02 |
Tohoku University |
Optimal osmotic range for a drug-containing solution suitable for lymphatic delivery
|
|
US12458592B1
(en)
|
2017-09-24 |
2025-11-04 |
Tris Pharma, Inc. |
Extended release amphetamine tablets
|
|
US11590081B1
(en)
|
2017-09-24 |
2023-02-28 |
Tris Pharma, Inc |
Extended release amphetamine tablets
|
|
WO2019084285A1
(en)
*
|
2017-10-26 |
2019-05-02 |
Qian Zhao |
FORMULATIONS OF A MACROCYCLIC TRK KINASE INHIBITOR
|
|
GB2585825B
(en)
*
|
2019-07-09 |
2023-03-22 |
Lexon Uk Holdings Ltd |
Suspending vehicle formulation
|
|
MA58173B1
(fr)
*
|
2019-12-23 |
2024-03-29 |
Nutra Essential Otc S L |
Composition liquide comprenant de l'ibuprofène et de la phényléphrine
|
|
CN112516083B
(zh)
*
|
2020-12-15 |
2023-02-28 |
太阳升(亳州)生物医药科技有限公司 |
布洛芬混悬液及其制备方法
|
|
CN120916749A
(zh)
|
2023-03-31 |
2025-11-07 |
科赴品牌有限责任公司 |
治疗性液体组合物
|
|
CN120916748A
(zh)
|
2023-03-31 |
2025-11-07 |
科赴品牌有限责任公司 |
治疗性悬浮液组合物
|
|
US20250110097A1
(en)
|
2023-09-29 |
2025-04-03 |
Kenvue Brands Llc |
Method for evaluating homogeneity of oral suspensions
|